Health Sciences Authority (HSA)
We wisely regulate health products, serve the administration of justice, secure the nation's blood supply, and safeguard public health.
Products Regulation
Medical devices
Registration, licensing, change notification, adverse events, FSCA, advertisements, product consultation, digital health
Therapeutic products
Registration, variations, reclassification, licensing, advertisements, product consultation
Cell, tissue and gene therapy products
Registration, variations, notifications, licensing, advertisement, product consultation
Cosmetic products
Classification, notification, ASEAN Cosmetic Directive
Chinese proprietary medicines
Product listing, licensing, advertisements
Traditional medicines
Labelling, ingredients, contaminants, advertisements
Health supplements
Safety and quality standards, claims, contaminants
Tobacco regulation
Licences, suspended and revoked licences, report offences
Other products and regulations
Find out more about other health products regulations including clinical trials, active ingredients, controlled drugs etc
Popular services
Announcements
Read the latest press releases.
HSA Investigating First Suspected Transnational Etomidate Vaporiser Pod Supply Syndicate under Tobacco and Vaporisers Control Act
30 June 2026
Keynote Address by Adj Prof (Dr) Raymond Chua, Chief Executive Officer, Health Sciences Authority, on "Regulatory Innovation as a Catalyst for Global Medtech Growth" for Singapore Medical Device Venture Showcase
29 June 2026
HSA and SRC Honours More Than 2,200 Blood Donors and Organisations, and Launches HealthPoints and yuu Points for Blood Donors at World Blood Donor Day
27 June 2026
View all press releases
Consumer Safety
Be more aware of how you consume health supplements, cosmetics, and other health products.
